Update: 01.11.2022
Last week: 42 week 2022 (17.10.2022 - 23.10.2022)
Last full month: September 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 135 902 | -7.7% | 3.6% | -0.1 | 29 505 362 | -6.6% | 3.8% | -0.1 | -4.7% |
| MoM | 747 528 | 79.1% | 3.7% | 0 | 153 590 034 | 85.1% | 3.8% | 0.1 | 81.0% |
| YTD | 8 182 874 | -16.5% | 5.3% | -1 | 1 630 320 774 | -1.8% | 5.1% | -0.6 | -0.8% |
| MAT | 11 653 046 | 0.5% | 5.6% | 0 | 2 260 226 854 | 16.1% | 5.4% | 0.3 | -0.3% |
| DEXALGIN | |||||||||
| WoW | 17 879 | -14.5% | 0.4% | 0 | 9 051 998 | -12.5% | 1.3% | -0.1 | -7.4% |
| MoM | 90 811 | 16.9% | 0.4% | 0 | 43 312 453 | 19.6% | 1.1% | 0 | 21.7% |
| YTD | 1 408 012 | 3.2% | 0.7% | 0 | 599 086 070 | 15.5% | 1.8% | 0.1 | 1.4% |
| MAT | 1 881 940 | 7.4% | 0.7% | 0 | 781 229 596 | 18.0% | 2.0% | 0.1 | 0.2% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 52 091 | -1.4% | 43.1% | 1.6 | 27 481 274 | -0.8% | 49.9% | 2.4 | -5.1% |
| MoM | 281 557 | 10.8% | 46.3% | -0.4 | 148 737 462 | 10.9% | 52.0% | -0.6 | 11.7% |
| YTD | 3 735 994 | -10.6% | 55.4% | -11.1 | 1 901 121 105 | 0.0% | 60.9% | -9.7 | 7.4% |
| MAT | 4 839 421 | -5.7% | 57.1% | -9 | 2 424 985 066 | 5.5% | 62.6% | -7.7 | 9.2% |
| ESPUMISAN BABY | |||||||||
| WoW | 21 819 | -3.4% | 32.0% | 0 | 14 209 229 | -3.5% | 45.2% | -0.1 | -3.5% |
| MoM | 112 687 | 10.3% | 34.9% | -0.1 | 73 791 527 | 12.4% | 48.2% | 0.5 | 10.7% |
| YTD | 1 195 031 | -11.5% | 37.9% | -3.8 | 746 632 028 | -5.1% | 51.2% | -5.4 | -2.6% |
| MAT | 1 507 450 | -12.2% | 38.3% | -3.5 | 931 620 248 | -5.0% | 51.8% | -4.4 | -4.2% |
| FASTUM | |||||||||
| WoW | 13 751 | -3.8% | 0.8% | 0 | 7 806 760 | -3.8% | 2.1% | 0 | -2.0% |
| MoM | 77 456 | 19.6% | 0.9% | 0 | 42 173 280 | 18.5% | 2.2% | 0.1 | 15.2% |
| YTD | 883 050 | -22.4% | 1.1% | -0.3 | 456 842 616 | -12.6% | 2.5% | -0.6 | 0.9% |
| MAT | 1 130 587 | -21.5% | 1.2% | -0.3 | 574 247 422 | -12.3% | 2.6% | -0.6 | 0.4% |
| IODOMARIN | |||||||||
| WoW | 71 551 | -9.5% | 23.0% | -0.2 | 13 357 290 | -8.4% | 9.8% | 0 | -8.6% |
| MoM | 335 689 | 32.6% | 24.3% | 2.3 | 62 171 772 | 28.4% | 10.7% | 1 | 20.3% |
| YTD | 2 610 089 | 6.9% | 20.1% | 0.1 | 513 909 976 | 12.0% | 9.0% | -0.1 | 6.5% |
| MAT | 3 334 201 | 20.6% | 20.6% | 2.3 | 647 377 682 | 22.7% | 9.3% | 0.9 | 7.3% |
| LIOTON | |||||||||
| WoW | 14 459 | -9.0% | 1.5% | -0.1 | 16 112 827 | -9.2% | 3.6% | -0.3 | -1.1% |
| MoM | 83 625 | -9.1% | 1.8% | -0.2 | 90 280 193 | -8.4% | 3.9% | -0.4 | 1.3% |
| YTD | 1 093 518 | -23.1% | 2.3% | -0.5 | 1 122 954 976 | -3.5% | 4.7% | -0.9 | -6.6% |
| MAT | 1 364 603 | -19.9% | 2.4% | -0.4 | 1 361 943 452 | -1.1% | 4.8% | -0.7 | -6.5% |
| MEZYM | |||||||||
| WoW | 201 659 | -2.3% | 18.9% | 0 | 30 658 294 | -1.5% | 13.6% | 0.3 | -2.4% |
| MoM | 1 012 478 | 8.5% | 18.9% | -0.8 | 154 387 022 | 9.1% | 13.4% | -0.5 | 13.2% |
| YTD | 15 112 709 | -5.3% | 26.9% | -1.4 | 2 311 868 684 | 3.7% | 19.2% | -1.9 | -0.4% |
| MAT | 19 917 559 | 0.7% | 28.0% | -0.1 | 2 991 565 821 | 8.3% | 20.2% | -0.9 | 1.1% |
| MIG 400 | |||||||||
| WoW | 125 717 | -6.0% | 2.8% | 0 | 15 185 708 | -6.3% | 2.2% | 0 | -7.4% |
| MoM | 705 306 | 16.2% | 2.8% | -0.1 | 83 916 288 | 16.1% | 2.2% | 0 | 21.7% |
| YTD | 7 037 272 | -12.0% | 3.3% | -0.5 | 828 857 587 | -7.9% | 2.5% | -0.6 | 1.4% |
| MAT | 8 930 426 | -7.7% | 3.4% | -0.3 | 1 045 169 336 | -3.8% | 2.6% | -0.4 | 0.2% |
| PROSTAMOL | |||||||||
| WoW | 21 674 | -8.2% | 14.9% | -0.7 | 30 019 472 | -6.6% | 15.8% | -0.6 | -4.0% |
| MoM | 107 142 | 27.2% | 15.1% | 0 | 149 162 441 | 25.9% | 16.1% | 0.2 | 27.1% |
| YTD | 1 315 861 | -24.1% | 19.2% | -5.9 | 1 844 163 461 | -15.1% | 20.5% | -6.9 | -0.7% |
| MAT | 1 723 372 | -19.7% | 19.9% | -4.7 | 2 371 528 176 | -11.4% | 21.2% | -5.6 | -0.9% |
| RESPERO MYRTOL | |||||||||
| WoW | 19 081 | -12.8% | 6.8% | -0.7 | 9 350 006 | -12.4% | 7.1% | -0.8 | -3.6% |
| MoM | 111 511 | 68.8% | 7.7% | -1.4 | 53 402 083 | 71.8% | 8.0% | -1.2 | 99.0% |
| YTD | 1 008 477 | 115.8% | 8.8% | 4.6 | 473 211 294 | 115.0% | 8.7% | 4.1 | 2.3% |
| MAT | 1 287 889 | 115.4% | 8.6% | 4.5 | 597 971 584 | 111.1% | 8.5% | 3.9 | 4.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 8 182 874 | -16.5% | 5.3% | -1 | 1 630 320 774 | -1.8% | 5.1% | -0.6 | -0.8% |
| DEXALGIN | 1 408 012 | 3.2% | 0.7% | 0 | 599 086 070 | 15.5% | 1.8% | 0.1 | 1.4% |
| ESPUMISAN (ADULTS) | 3 735 994 | -10.6% | 55.4% | -11.1 | 1 901 121 105 | 0.0% | 60.9% | -9.7 | 7.4% |
| ESPUMISAN BABY | 1 195 031 | -11.5% | 37.9% | -3.8 | 746 632 028 | -5.1% | 51.2% | -5.4 | -2.6% |
| FASTUM | 883 050 | -22.4% | 1.1% | -0.3 | 456 842 616 | -12.6% | 2.5% | -0.6 | 0.9% |
| IODOMARIN | 2 610 089 | 6.9% | 20.1% | 0.1 | 513 909 976 | 12.0% | 9.0% | -0.1 | 6.5% |
| LIOTON | 1 093 518 | -23.1% | 2.3% | -0.5 | 1 122 954 976 | -3.5% | 4.7% | -0.9 | -6.6% |
| MEZYM | 15 112 709 | -5.3% | 26.9% | -1.4 | 2 311 868 684 | 3.7% | 19.2% | -1.9 | -0.4% |
| MIG 400 | 7 037 272 | -12.0% | 3.3% | -0.5 | 828 857 587 | -7.9% | 2.5% | -0.6 | 1.4% |
| PROSTAMOL | 1 315 861 | -24.1% | 19.2% | -5.9 | 1 844 163 461 | -15.1% | 20.5% | -6.9 | -0.7% |
| RESPERO MYRTOL | 1 008 477 | 115.8% | 8.8% | 4.6 | 473 211 294 | 115.0% | 8.7% | 4.1 | 2.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 11 653 046 | 0.5% | 5.6% | 0 | 2 260 226 854 | 16.1% | 5.4% | 0.3 | -0.3% |
| DEXALGIN | 1 881 940 | 7.4% | 0.7% | 0 | 781 229 596 | 18.0% | 2.0% | 0.1 | 0.2% |
| ESPUMISAN (ADULTS) | 4 839 421 | -5.7% | 57.1% | -9 | 2 424 985 066 | 5.5% | 62.6% | -7.7 | 9.2% |
| ESPUMISAN BABY | 1 507 450 | -12.2% | 38.3% | -3.5 | 931 620 248 | -5.0% | 51.8% | -4.4 | -4.2% |
| FASTUM | 1 130 587 | -21.5% | 1.2% | -0.3 | 574 247 422 | -12.3% | 2.6% | -0.6 | 0.4% |
| IODOMARIN | 3 334 201 | 20.6% | 20.6% | 2.3 | 647 377 682 | 22.7% | 9.3% | 0.9 | 7.3% |
| LIOTON | 1 364 603 | -19.9% | 2.4% | -0.4 | 1 361 943 452 | -1.1% | 4.8% | -0.7 | -6.5% |
| MEZYM | 19 917 559 | 0.7% | 28.0% | -0.1 | 2 991 565 821 | 8.3% | 20.2% | -0.9 | 1.1% |
| MIG 400 | 8 930 426 | -7.7% | 3.4% | -0.3 | 1 045 169 336 | -3.8% | 2.6% | -0.4 | 0.2% |
| PROSTAMOL | 1 723 372 | -19.7% | 19.9% | -4.7 | 2 371 528 176 | -11.4% | 21.2% | -5.6 | -0.9% |
| RESPERO MYRTOL | 1 287 889 | 115.4% | 8.6% | 4.5 | 597 971 584 | 111.1% | 8.5% | 3.9 | 4.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 135 902 | -7.7% | 3.6% | -0.1 | 29 505 362 | -6.6% | 3.8% | -0.1 | -4.7% |
| DEXALGIN | 17 879 | -14.5% | 0.4% | 0 | 9 051 998 | -12.5% | 1.3% | -0.1 | -7.4% |
| ESPUMISAN (ADULTS) | 52 091 | -1.4% | 43.1% | 1.6 | 27 481 274 | -0.8% | 49.9% | 2.4 | -5.1% |
| ESPUMISAN BABY | 21 819 | -3.4% | 32.0% | 0 | 14 209 229 | -3.5% | 45.2% | -0.1 | -3.5% |
| FASTUM | 13 751 | -3.8% | 0.8% | 0 | 7 806 760 | -3.8% | 2.1% | 0 | -2.0% |
| IODOMARIN | 71 551 | -9.5% | 23.0% | -0.2 | 13 357 290 | -8.4% | 9.8% | 0 | -8.6% |
| LIOTON | 14 459 | -9.0% | 1.5% | -0.1 | 16 112 827 | -9.2% | 3.6% | -0.3 | -1.1% |
| MEZYM | 201 659 | -2.3% | 18.9% | 0 | 30 658 294 | -1.5% | 13.6% | 0.3 | -2.4% |
| MIG 400 | 125 717 | -6.0% | 2.8% | 0 | 15 185 708 | -6.3% | 2.2% | 0 | -7.4% |
| PROSTAMOL | 21 674 | -8.2% | 14.9% | -0.7 | 30 019 472 | -6.6% | 15.8% | -0.6 | -4.0% |
| RESPERO MYRTOL | 19 081 | -12.8% | 6.8% | -0.7 | 9 350 006 | -12.4% | 7.1% | -0.8 | -3.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 747 528 | 79.1% | 3.7% | 0 | 153 590 034 | 85.1% | 3.8% | 0.1 | 81.0% |
| DEXALGIN | 90 811 | 16.9% | 0.4% | 0 | 43 312 453 | 19.6% | 1.1% | 0 | 21.7% |
| ESPUMISAN (ADULTS) | 281 557 | 10.8% | 46.3% | -0.4 | 148 737 462 | 10.9% | 52.0% | -0.6 | 11.7% |
| ESPUMISAN BABY | 112 687 | 10.3% | 34.9% | -0.1 | 73 791 527 | 12.4% | 48.2% | 0.5 | 10.7% |
| FASTUM | 77 456 | 19.6% | 0.9% | 0 | 42 173 280 | 18.5% | 2.2% | 0.1 | 15.2% |
| IODOMARIN | 335 689 | 32.6% | 24.3% | 2.3 | 62 171 772 | 28.4% | 10.7% | 1 | 20.3% |
| LIOTON | 83 625 | -9.1% | 1.8% | -0.2 | 90 280 193 | -8.4% | 3.9% | -0.4 | 1.3% |
| MEZYM | 1 012 478 | 8.5% | 18.9% | -0.8 | 154 387 022 | 9.1% | 13.4% | -0.5 | 13.2% |
| MIG 400 | 705 306 | 16.2% | 2.8% | -0.1 | 83 916 288 | 16.1% | 2.2% | 0 | 21.7% |
| PROSTAMOL | 107 142 | 27.2% | 15.1% | 0 | 149 162 441 | 25.9% | 16.1% | 0.2 | 27.1% |
| RESPERO MYRTOL | 111 511 | 68.8% | 7.7% | -1.4 | 53 402 083 | 71.8% | 8.0% | -1.2 | 99.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs